KMT Hepatech, Inc., a part of PhoenixBio group, announced plans to expand staff and operations by providing services with PXB-Mouse® and starting the production of the PXB-Cells® – hepatocytes isolated from cDNA-uPA/SCID mice with highly humanized liver.
New biotech spinoff with roots in a GlycoNet project is planning to capitalize on the discovery of a novel cancer-specific sugar to develop new diagnostic tools and drugs for prostate cancer.
KMT Hepatech announces strategic investment from PhoenixBio to join forces to advance the use of a mouse model with highly humanized liver.
Botaneco Inc. was recently named the Alberta Bioindustry "Company of the Year." The award was presented to President and CEO, James Szarko, at the BioAlberta Achievement Awards Gala.
Edmonton-based BioNeutra is a 2017 Finalist for ASTech Awards for Science and Technology. The company takes a unique approach to trying to help solve this global healthcare problem with a low calorie, natural sweetener: VitaFiber™ .
Quest PharmaTech Inc., an Edmonton-based pharmaceutical company, announce the appointment of Mark Lievonen, to the
company's Board of Directors.
New partnerships with the University Hospital Foundation and leading pharmaceutical companies, Servier and Merck, will help dozens of Alberta health innovators market their discoveries to the world.
Edmonton’s General Intermediates of Canada Inc. (GIC) announced they have successfully completed a research project related to a key starting API material for a global pharmaceutical client.
Yesterday the innovative pharmaceutical industry and the Government of Alberta solidified a collaboration to ignite the life sciences sector in Alberta.